Industry Experts

Kevin King, Senior Director of CGT Strategy and Growth at BIOIVT.  As a leader in the Cell and Gene Therapy collection industry Kevin has over 32 years experience.  His degree and training is in Organizational Management.  He has built, opened, and operated 7 commercial apheresis facilities including founding his previous company PPA Research Group in 2009 which was purchased by BIOIVT in 2019.  Most recently Kevin has worked for BIOIVT to grow our donor center network and enhance our capabilities for Cell and Gene Therapies.  He led efforts to provide GMP compliant ATMP starting materials in the US and facilitated the Human Tissue Authority licensure for ATMP starting materials in the UK.  His work has included executive leadership, operational, strategic and regulatory advice, market intelligence and competitive analysis, planning and facilitating ATMP facility build outs, medical direction oversight and training, and offers management support and oversight of BIOIVT’s 10 donor collection facilities.